We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Dim4.0
DIM Research
Likely helps
40 peer-reviewed studies
What the evidence says
Probably helps
DIM helped in about half (2/3) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality randomised trials published 2004–2026 with a typical study size of 19 participants.
Based on 40 studies · 12 RCTs · 227 total participants
Confidence
Moderate confidence
What the studies found
2helped1unclear· 37 more without graded effect data
By outcome
Cancer chemoprevention
Probably helps35 studies
Women's healthMarketed for estrogen metabolism; human evidence is limited and inconsistent · 4-8 weeks · No reliable human evidence for menopausal symptom relief · 4-8 weeks
Mostly mechanism / observational8 studies
Men's vitalityTargets estrogen metabolism, but human effects on estrogen ratios are mixed and often null · 4-8 weeks
Mostly mechanism / observational7 studies
Safety & pharmacokinetics
Mostly mechanism / observational5 studies
Inflammation
Mostly mechanism / observational3 studies
Liver healthDetox-pathway effects are preclinical only; no human outcome data · 4-12 weeks
Too few graded studies2 studies
Weight management
Too few graded studies2 studies
Digestive health
Too few graded studies1 study
By the numbers
Pulled from 26 studies with measurable effects
People studied
227
typical study: 19 people
Strongest designs
12
0 pooled, 12 randomised
Showed benefit
67%
2/3 studies
How long studies ran
1–3 months
3
3+ months
1
Populations Studied
Cancer patients4
Breast cancer patients3
Prostate cancer patients3
In vitro and in vivo models1
Active research area
13 studies in the last 5 years
200420152026
1Breast cancer risk reductionReview2025
In plain English: Integrating cruciferous vegetables and their bioactive compounds in light of an individual's microbiome profile as a complementary approach alongside standard treatments is a promising strategy in breast cancer care.
Ho E et al. · Annual review of nutrition (2025)
Breast cancer is a heterogeneous disease with varying subtypes, prognoses, and treatment responses.
Cruciferous vegetables have shown promise in reducing breast cancer risk.
Integrating cruciferous vegetables and their bioactive compounds in light of an individual's microbiome profile as a complementary approach alongside standard treatments is a promising strategy in breast cancer care.
2Prevention and treatment of chronic diseases including inflammation, obesity, diabetes, cardiovascular disease, cancer, hypertension, neurodegenerative diseases, and osteoporosisReview2023
In plain English: This article reviews current knowledge of the occurrence of I3C in nature and foods, along with the beneficial effects of I3C and DIM concerning prevention and treatment of human chronic diseases, focusing on preclinical studies and their mechanisms of action at cellular and molecular levels.
Amarakoon D et al. · Annual review of food science and technology (2023)
One of its main in vivo metabolites is 3,3'-diindolylmethane (DIM), formed by the condensation of two molecules of I3C.
Both I3C and DIM alter multiple signaling pathways and related molecules controlling diverse cellular events, including oxidation, inflammation, proliferation, differentiation, apoptosis, angiogenesis, and immunity.
There is a growing body of evidence from both in vitro and in vivo models that these compounds possess strong potential to prevent several forms of chronic disease such as inflammation, obesity, diabetes, cardiovascular disease, cancer, hypertension, neurodegenerative diseases, and osteoporosis.
3Cancer treatment through epigenetic mechanisms including DNA methylation, histone acetylation and microRNAs expressionReview2023
In plain English: DNA methylation, histone acetylation and microRNAs expression in cancer treatment.
Anchimowicz J et al. · Postepy biochemii (2023)
The favourable effect on health exert glucosinolates (GSLs), a group of secondary plant metabolites found in vegetables of the Brassicaceae family, such as broccoli, cauliflower, cabbage, and kohlrabi.
Hydrolysis of GSLs results in the formation of compounds, like sulforaphane (SFN), phenylethyl isothiocyanate (PEITC) and 3,3′-Diindolylmethane (DIM), which are known for versatile anti-cancer activity.
This review highlights advances on the role of the chosen GSLs on selected epigenetic mechanisms, i.e.
4Breast cancer treatment effectiveness and side effect reductionReview2023
In plain English: The future perspectives on the translation of these findings to the personalized treatment of BC are provided and discussed.
Singla RK et al. · Critical reviews in food science and nutrition (2023)
Evidence from clinical trials suggests that such products had major potential in enhancing the effectiveness of conventional antitumor agents and decreasing their side effects.
We here provide a comprehensive review of the therapeutic effects and mechanistic underpinnings of medicinal plants and microbial metabolites in BC management.
The future perspectives on the translation of these findings to the personalized treatment of BC are provided and discussed.
5Liver disease treatment through modulation of cell proliferation, apoptosis, oxidative stress, and lipogenesisReview2024
In plain English: Mechanistically, I3C and DIM modulate various pathophysiological processes, including cell proliferation, apoptosis, oxidative stress, and lipogenesis.
Tian C et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
Mechanistically, I3C and DIM modulate various pathophysiological processes, including cell proliferation, apoptosis, oxidative stress, and lipogenesis.
This review aims to enhance researchers' understanding of the regulatory roles of I3C and DIM in these liver diseases and explore the potential of plant-derived substances in liver disease treatment.
6Inflammatory bowel disease protection through Th17/Treg balance regulationReview2021
In plain English: Recently, a growing body of studies has indicated that phytochemicals derived from natural products are potent regulators of Th17/Treg, and exert preferable protective benefits against colonic infl...
Chang Y et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2021)
Recently, a growing body of studies has indicated that phytochemicals derived from natural products are potent regulators of Th17/Treg, and exert preferable protective benefits against colonic inflammation.
8Prostate cancer treatment with AR and PSA inhibitionReview2016
In plain English: BR-DIM administered in clinical trials was well tolerated, and 93% of patients had detectable prostatic DIM levels.
Li Y et al. · Medical principles and practice : international journal of the Kuwait University, Health Science Centre (2016)
Huge benefit
← WorseNo effectBetter →
BR-DIM administered in clinical trials was well tolerated, and 93% of patients had detectable prostatic DIM levels.
The inhibitory effects of BR-DIM on AR and AR target gene such as prostate-specific antigen were also observed in the clinical trial.
Our preclinical and clinical studies provide the scientific basis for a 'proof-of-concept' clinical trial in CRPC patients treated with enzalutamide in combination with BR-DIM.
10Nutraceutical treatment outcomes in prostate cancerReview2014
In plain English: Such strategy could become a promising newer approach for the treatment of metastatic PCa with better treatment outcome by improving overall survival.
Li Y et al. · Cancer metastasis reviews (2014)
Therefore, nutraceutical treatment in combination with conventional therapeutics could achieve better treatment outcome in prostate cancer therapy.
Interestingly, some nutraceuticals could regulate the function of cancer stem cell (CSC)-related miRNAs and associated molecules, leading to the inhibition of prostatic CSCs which are responsible for drug resistance, tumor progression, and recurrence of PCa.
Such strategy could become a promising newer approach for the treatment of metastatic PCa with better treatment outcome by improving overall survival.
In plain English: Together, our pre-clinical studies demonstrate that DIM has activity against ovarian cancer and hence should be further investigated in clinical setting to exploit its therapeutic potential.
Kandala PK et al. · Current drug targets (2012)
In the present review article, we describe the anti-cancer effects of 3, 3'-diindolylmethane (DIM), a compound present in cruciferous vegetables, against ovarian cancer.
DIM targets multiple aspects of cancer such as cellcycle regulation and survival, including EGFR-JAK2-STAT3 signaling, checkpoint activation, caspase activation, endoplasmic reticulum stress, autophagy and anoikis.
This broad spectrum of anti-cancer activities in conjunction with low systemic toxicity accentuates the translational value of DIM in cancer therapy.
12I3C and DIM role in chronic disease preventionReview2016
In plain English: This chapter summarizes the current experimental data on the I3C and DIM activity and the results of clinical studies indicating their role in prevention of chronic diseases.
Licznerska B et al. · Advances in experimental medicine and biology (2016)
Initially, these compounds were classified as blocking agents that increase drug-metabolizing enzyme activity.
Now it is widely accepted that I3C and DIM affect multiple signaling pathways and target molecules controlling cell division, apoptosis, or angiogenesis deregulated in cancer cells.
Although most of the current data support the role of I3C and DIM in prevention of hormone-dependent cancers, it seems that their application in prevention of the other cancer as well as cardiovascular disease, obesity, and diabetes reduction is also possible.
13Cancer prevention and therapy with isoflavone and DIMReview2013
In plain English: However, more clinical trials are needed to evaluate the effects of isoflavone and DIM for the prevention of cancer development and also for the treatment of cancer either alone or in combination with conventional cancer therapeutics.
Li Y et al. · Antioxidants & redox signaling (2013)
In plain English: Indoles, especially I3C and DIM as phytochemicals, exert anti-fibrosis, anti-tumor, anti-oxidant, immunomodulatory, detoxification and anti-inflammation effects on hepatic protection through pleiotropic mechanism.
Wang SQ et al. · Current drug metabolism (2016)
Indoles, especially I3C and DIM as phytochemicals, exert anti-fibrosis, anti-tumor, anti-oxidant, immunomodulatory, detoxification and anti-inflammation effects on hepatic protection through pleiotropic mechanism.
15Gastrointestinal cancer prevention and treatmentReview2016
In plain English: Therefore, this review provides a comprehensive understanding of the preventive and therapeutic properties of DIM in addition to its different perspective on the safety of DIM in clinical applications for the treatment of gastrointestinal cancers.
Kim SM · International journal of molecular sciences (2016)
DIM acts upon several cellular and molecular processes in gastrointestinal cancer cells, including apoptosis, autophagy, invasion, cell cycle regulation, metastasis, angiogenesis, and endoplasmic reticulum (ER) stress.
In addition, DIM increases the efficacy of other drugs or therapeutic chemicals when used in combinatorial treatment for gastrointestinal cancer.
The studies to date offer strong evidence to support the use of DIM as an anticancer and therapeutic agent for gastrointestinal cancer.
In plain English: This review emphasizes the therapeutic potential of I3C and its derivatives for concurrently activating neuronal defense mechanisms in the treatment of neurodegenerative diseases.
Singh AA, Yadav D, Khan F, Song M. · Brain sciences (2024)
However, insufficient neurotrophin support often leads to the downregulation of the TrkB signaling pathway in brain diseases.
Thus, targeting TrkB activation and the Nrf2-ARE system is a promising therapeutic strategy for treating neurodegenerative diseases.
This review emphasizes the therapeutic potential of I3C and its derivatives for concurrently activating neuronal defense mechanisms in the treatment of neurodegenerative diseases.
In plain English: Although definitive trials need to use a robust clinical endpoint (such as histology), all future trials should include biomarkers to study the subclinical effect of the study agent.
Sasieni P · Best practice & research. Clinical obstetrics & gynaecology (2006)
Randomised controlled clinical trials have generally been small and the results have not been encouraging.
Beneficial effects on neoplasia have been shown for a couple of agents that have since been abandoned due to adverse side-effects.
Indoles were used successfully in a very small clinical trial of women with high-grade cervical intraepithelial neoplasia and a larger trial using diindolylmethane in women with mildly abnormal cervical smears is underway.
In plain English: While the current information is intriguing, future I3C research needs to focus on why these changes in nuclear transcription factors occur and how they relate to phenotypic responses and the quantity and duration of exposure to I3C and its dimer 3,3'-diindolylmethane.
Kim YS et al. · The Journal of nutritional biochemistry (2005)
Mounting preclinical and clinical evidence indicate that indole-3-carbinol (I3C), a key bioactive food component in cruciferous vegetables, has multiple anticarcinogenic and antitumorigenic properties.
Evidence that p21, p27, cyclin-dependent kinases, retinoblastoma, Bax/Bcl-2, cytochrome P-450 1A1 and GADD153 are targets for I3C already exists.
Modification of nuclear transcription factors including Sp1, estrogen receptor, nuclear factor kappaB and aryl hydrocarbon receptor may represent a common site of action to help explain downstream cellular responses to dietary I3C and, ultimately, to its anticancer properties.
20Cancer prevention and treatment through cellular signaling pathway regulationReview2009
In plain English: Therefore, non-toxic "natural agents" harvested from the bounties of nature could be useful either alone or in combination with conventional therapeutics for the prevention of tumor progression and/or treatment of human malignancies.
Sarkar FH et al. · Cellular signalling (2009)
This is also consistent with the epidemiological studies showing that the consumption of fruits, soybean and vegetables is associated with reduced risk of several types of cancers.
By regulating multiple important cellular signaling pathways including NF-kappaB, Akt, MAPK, Wnt, Notch, p53, AR, ER, etc, these natural products are known to activate cell death signals and induce apoptosis in pre-cancerous or cancer cells without affecting normal cells.
Therefore, non-toxic "natural agents" harvested from the bounties of nature could be useful either alone or in combination with conventional therapeutics for the prevention of tumor progression and/or treatment of human malignancies.